20.46
Doximity Inc stock is traded at $20.46, with a volume of 4.48M.
It is up +0.05% in the last 24 hours and up +4.49% over the past month.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
See More
Previous Close:
$20.45
Open:
$20.39
24h Volume:
4.48M
Relative Volume:
1.17
Market Cap:
$3.74B
Revenue:
$644.86M
Net Income/Loss:
$196.05M
P/E Ratio:
20.85
EPS:
0.9812
Net Cash Flow:
$317.50M
1W Performance:
+2.20%
1M Performance:
+4.49%
6M Performance:
-52.95%
1Y Performance:
-64.13%
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DOCS
Doximity Inc
|
20.46 | 3.74B | 644.86M | 196.05M | 317.50M | 0.9812 |
|
VEEV
Veeva Systems Inc
|
153.30 | 24.90B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
66.25 | 13.00B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
50.84 | 9.13B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
85.21 | 7.12B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
69.42 | 5.37B | 646.34M | -512.40M | 202.76M | -6.6871 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-20-26 | Downgrade | Truist | Buy → Hold |
| Apr-08-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity (DOCS) CFO discloses 501,549 shares, including 499,722 RSUs, on Form 3 - Stock Titan
Doximity (DOCS) President Steven Zatz receives 55,524 restricted stock units - Stock Titan
Doximity (NYSE: DOCS) president discloses 822 Class A shares - Stock Titan
Doximity Inc (DOCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Doximity Inc (DOCS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Doximity Inc (DOCS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Doximity Inc (DOCS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Doximity Inc (DOCS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Doximity Inc (DOCS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Doximity Inc (DOCS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Doximity Inc (DOCS) Institutional Confidence - TradingKey
Doximity (DOCS) Advances While Market Declines: Some Information for Investors - Yahoo Finance Singapore
Doximity, Inc. (DOCS) Stock Analysis: Exploring a 26.85% Potential Upside in Health Information Services - DirectorsTalk Interviews
Responsive Playbooks and the DOCS Inflection - Stock Traders Daily
Y Intercept Hong Kong Ltd Invests $9 Million in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Shares Purchased by Rhenman & Partners Asset Management AB - MarketBeat
Doximity (DOCS) up 11.2% since last earnings report: Can it continue? - MSN
Doximity: Cheaper, But Growth Is Still Missing (NYSE:DOCS) - Seeking Alpha
Is Doximity Struggling After Revenue Miss? - Kalkine Media
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance Australia
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Doximity (DOCS) and Axsome Therapeutics (AXSM) - The Globe and Mail
Doximity (DOCS) Institutional Ownership 2026 $DOCS - MarketBeat
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Inv - GuruFocus
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc.DOCS - PR Newswire
Doximity interim PAO Sitaram Siddharth sells $49,882 in shares By Investing.com - Investing.com Canada
Doximity interim PAO Sitaram Siddharth sells $49,882 in shares - Investing.com UK
symbol__ Stock Quote Price and Forecast - CNN
Doximity (DOCS) interim PAO trades shares under 10b5-1 plan, exercises options - Stock Titan
AI Margin Pressure And Legal Probe Might Change The Case For Investing In Doximity (DOCS) - simplywall.st
Doximity hits an all-time low after Q4 results; KeyBanc downgrades - MSN
[144] Doximity, Inc. SEC Filing - Stock Titan
Capital World Investors Has $250.40 Million Holdings in Doximity, Inc. $DOCS - MarketBeat
DOCS (NASDAQ: DOCS) Form 144 reports 2,444-share sale via exercise - Stock Titan
Doximity shares drop 23% after missing revenue targets and AI investment warning - Pluang
Doximity, Inc. (DOCS) Stock Analysis: Exploring a 22.15% Potential Upside in the Healthcare Information Sector - DirectorsTalk Interviews
Doximity(DOCS) Stock Options Chain | Quotes & News - Moomoo
Law firm investigates Doximity officers for possible shareholder rights breaches - Pluang
BofA Securities Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $38 - Moomoo
DOCS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
2026-06-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Doximity, Inc. (DOCS) and Encourages Shareholders to Learn More About the Investigation | NYSE:DOCS | Press Release - Stockhouse
Doximity stock falls on Q4 earnings miss, revenues beat, margins down - MSN
Legal & General Group Plc Sells 54,024 Shares of Doximity, Inc. $DOCS - MarketBeat
BNP Paribas Financial Markets Raises Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. (DOCS) Investigation: Bronstein, Gewirtz & Grossma - The National Law Review
Doximity, Inc. (DOCS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Doximity (NYSE:DOCS) Downgraded by Zacks Research to Strong Sell - MarketBeat
Workday and Doximity shares are soaring, what you need to know - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Doximity, Inc. (DOCS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Understanding the Setup: (DOCS) and Scalable Risk - Stock Traders Daily
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):